Khavinson Bioregulators

A class of short peptides (2-4 amino acids) developed by Prof. Vladimir Khavinson for modulating gene expression in specific organs.

What Are Peptide Bioregulators?

Peptide bioregulators are ultra-short peptides — 2 to 4 amino acids — that act as epigenetic regulators. Unlike larger peptides that function as receptor ligands, these short peptides interact directly with DNA, modulating the transcription of specific genes in target tissues.

Research on this class began in the 1970s at the Institute of Bioregulation and Gerontology in St. Petersburg, under the leadership of Prof. Vladimir Khavinson. The central idea is that each organ has endogenous regulatory peptides, and that exogenous administration of these peptides can restore gene function compromised by aging or disease.

Mechanism of Action

Khavinson bioregulators act through a mechanism distinct from traditional pharmacological peptides. Instead of activating membrane receptors, these short peptides penetrate the cell nucleus and interact with specific DNA regions, influencing gene expression in an organ-specific manner.

  • Epigenetic regulation: Modulate chromatin condensation/decondensation, making genes accessible or inaccessible for transcription
  • Tissue specificity: Each peptide has affinity for DNA sequences predominant in specific tissues (cardiac, neural, thymic, etc.)
  • Restorative effect: Tend to normalize gene expression — they neither over-stimulate nor suppress, but restore physiological patterns
  • Short cycles: Typically administered in 10-20 day cycles, repeated 2-4 times per year, with effects lasting months

Classification

Khavinson bioregulators are divided into two groups:

Cytomidines (Glandular)

Extracted from young animal tissues by acid hydrolysis. Contain complex mixtures of short peptides. Historical examples include Thymalin (thymus) and Epithalamine (pineal).

Cytogens (Synthetic)

Synthetic peptides of defined sequence (2-4 amino acids) that replicate the activity of the active components of cytomidines. Purer, reproducible, and with better-characterized mechanisms.

Prof. Vladimir Khavinson

Vladimir Khavinson is a gerontologist and professor at the Institute of Bioregulation and Gerontology in St. Petersburg, Russia. With more than 200 patents and hundreds of publications, his research focuses on peptide regulation of aging. He is a member of the European Academy of Sciences and president of the Russian Society of Gerontology.

His work demonstrated that short peptides can restore the function of aging organs in animal models, with clinical studies in humans showing effects on immunity (Thymalin), pineal function (Epithalon), and other systems.

Bioregulator Catalogue (18 peptides)

Important Notes

  • Khavinson bioregulators are widely researched in Russia and Eastern European countries. Clinical evidence varies among different peptides.
  • These peptides are classified as research substances. They are not approved as medicines by most Western regulatory agencies.
  • The information on this page is educational in nature and does not constitute medical advice.